In the UCLA accelerated TMS study, some patients showed no measurable improvement during the five-day treatment period but experienced strong symptom relief weeks afterward. This delayed response was unexpected — the standard model assumes that if stimulation works, it works during or shortly after the stimulation period. A treatment that appears to fail and then succeeds raises a methodological problem: how long must you wait before declaring a treatment ineffective?
The structural insight is about the distinction between the stimulus and its consequences. Magnetic stimulation delivers energy to specific neural circuits. The energy deposition is immediate — pulses arrive, neurons fire, circuits activate. But the therapeutic effect — the sustained change in mood regulation — depends on neuroplastic remodeling that unfolds on its own timeline. The stimulation initiates a process; the process completes itself without further stimulation. The treatment is not the pulses. The treatment is the remodeling the pulses trigger.
This inverts the usual relationship between dose and response. In pharmacology, the drug is present when the effect occurs. In accelerated TMS, the stimulus is gone before the effect appears. The patient experiences a gap between intervention and outcome during which nothing observable happens. From the outside, this looks like failure followed by spontaneous improvement. From the inside, it is a single causal chain with a long delay. The bloom was planted during stimulation. It emerged on its own schedule.